与二皮里丁通道阻断剂相关的精神疾病不良事件:基于FAERS数据库的药监测研究
Huafeng Jiang1,2, Yimin Lin1, Lidan Tu3
1Department of Pharmacy, The People's Hospital of Cangnan, Wenzhou, Zhejiang Province, China.
双胺酸通道阻断剂 (DHPCCBs) 可能与精神病不良事件 (PAE) 相关,特别是自杀行为,在治疗的前30天内. 需要进一步的研究来证实这些发现.
科学领域:
- 药物监督 药物监督 药物监督
- 心血管药理学心血管药理学
- 精神病学是一个精神病学.
背景情况:
- 二皮里丁通道阻断剂 (DHPCCBs) 是常见的心血管药物.
- 以前的研究暗示了DHPCCBs和精神病不良事件 (PAE) 之间的可能联系,但缺乏全面的分析.
研究的目的:
- 通过使用大型不良事件数据库,系统地调查DHPCCB和PAE之间的潜在关联.
- 确定需要进一步调查的特定DHPCCB和PAE.
主要方法:
- 使用FDA不良事件报告系统 (FAERS) 数据库对七个DHPCCB进行了分析.
- 使用不成比例分析提取和分析精神病学不良事件报告.
主要成果:
- 在七个DHPCCB中确定了9164个PAE,有18个正信号关联.
- 阿姆洛迪平对完成的自杀和自杀企图显示了显著的信号. 尼菲迪平的信号较少.
- 大多数PAE发生在治疗开始后的30天内;在调整后,11个信号与自杀行为有关.
结论:
- 不成比例性分析揭示了DHPCCB和PAE之间的潜在关联,包括自杀行为.
- 这些发现是产生假设的,需要通过受控临床研究进行验证.
- 临床医生应考虑监测使用DHPCCB的患者的精神症状,特别是那些高风险患者.
更多相关视频
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antihypertensive Drugs: Action of Calcium Channel Blockers
Therapeutic Drug Monitoring: Affecting Factors
